The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment
Current Diabetes Reports, ISSN: 1539-0829, Vol: 21, Issue: 10, Page: 40
2021
- 19Citations
- 53Captures
- 28Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations19
- Citation Indexes19
- 19
- CrossRef1
- Captures53
- Readers53
- 53
- Mentions28
- News Mentions27
- News27
- Blog Mentions1
- Blog1
Most Recent Blog
The Disproportionate Toll That COVID-19 Took On People With Diabetes Continues Today
Hundreds of millions of people worldwide have diabetes.
Most Recent News
The Disproportionate Toll That COVID-19 Took on People With Diabetes Continues Today
09/16/2024 At the start of the pandemic, many people living with diabetes were wondering what COVID-19 meant for them. Diabetes was already known to put
Review Description
Purpose of Review: Diabetic retinopathy (DR) is one of the leading causes of vision loss worldwide. Although screening and early treatment guidelines for DR have significantly reduced the disease burden, restrictions related to the COVID-19 pandemic have changed real-world practice patterns in the management of DR. This review summarizes evolving guidelines and outcomes of the treatment of DR in the setting of the pandemic. Recent Findings: Intravitreal injections for DR have decreased significantly globally during the pandemic, ranging from approximately 30 to nearly 100% reduction, compared to corresponding timepoints in 2019. Most studies on functional outcomes show a decrease in visual acuity on delayed follow-up. Summary: Changing practice patterns in the management of DR has led to fewer intravitreal injections and overall reduction in visual acuity on follow-up. As COVID variants emerge, it will be necessary to continue evaluating practice guidelines.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85114514409&origin=inward; http://dx.doi.org/10.1007/s11892-021-01411-6; http://www.ncbi.nlm.nih.gov/pubmed/34495377; https://link.springer.com/10.1007/s11892-021-01411-6; https://dx.doi.org/10.1007/s11892-021-01411-6; https://link.springer.com/article/10.1007/s11892-021-01411-6
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know